Blood Glucose Monitoring Devices Market is expected to exceed more than US$ 20.50 Billion by 2028 at a CAGR of 7% in the given forecast period.
Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propellant the expansion of this market. Additionally, continuous technological advancements in blood sugar monitoring devices and rise in aging population are more stimulating the demand for blood sugar monitoring devices. However, inadequate compensation and high value related to the appliance of CGM systems and products recalls are a number of the key factors hampering the expansion of this market.
Market Insights
The global Blood Glucose Monitoring Devices market is segregated on the basis of Type as Glucose Oxidase, Glucose Dehydrogenase, and Other. Based on Application the global Blood Glucose Monitoring Devices market is segmented in Hospital, Clinic, and Home Care.
The global Blood Glucose Monitoring Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Blood Glucose Monitoring Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
F.Hoffmann-La Roche, Abbott Laboratories, Bayer, Healthcare AG, LifeScan, and others are among the major players in the global Blood Glucose Monitoring Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Blood Glucose Monitoring Devices Market has been segmented as below:
Blood Glucose Monitoring Devices Market, By Type
Blood Glucose Monitoring Devices Market, By Application
Blood Glucose Monitoring Devices Market, By Region
Blood Glucose Monitoring Devices Market, By Company
The report covers:
Report Scope:
The global Blood Glucose Monitoring Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Blood Glucose Monitoring Devices market share. Major industry players with significant revenue share include F.Hoffmann-La Roche, Abbott Laboratories, Bayer, Healthcare AG, LifeScan, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Brain Mapping Instruments Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Blood Glucose Monitoring Devices Market, By Type
5.1 Introduction
5.2 Glucose Oxidase
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Glucose Dehydrogenase
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Blood Glucose Monitoring Devices Market, By Application
6.1 Introduction
6.2 Hospital
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Clinic
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Home Care
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Blood Glucose Monitoring Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Blood Glucose Monitoring Devices, By Type
7.2.2 North America Blood Glucose Monitoring Devices, By Application
7.3 Europe
7.3.1 Europe Blood Glucose Monitoring Devices, By Type
7.3.2 Europe Blood Glucose Monitoring Devices, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Blood Glucose Monitoring Devices, By Type
7.4.2 Asia-Pacific Blood Glucose Monitoring Devices, By Application
7.5 Rest of the World
7.5.1 Rest of the World Blood Glucose Monitoring Devices, By Type
7.5.2 Rest of the World Blood Glucose Monitoring Devices, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 F.Hoffmann-La Roche
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Bayer
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Healthcare AG
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 LifeScan
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
The Blood Glucose Monitoring Devices Market has been segmented as below:
Blood Glucose Monitoring Devices Market, By Type
Blood Glucose Monitoring Devices Market, By Application
Blood Glucose Monitoring Devices Market, By Region
Blood Glucose Monitoring Devices Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
